An interventional study of Hybrid-Model Breastfeeding Education in Breastfeeding and Postpartum Comfort, sponsored by Kutahya Health Sciences University. Enrolling by invitation at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-28.
Sponsored by Kutahya Health Sciences University · Not applicable, Interventional, and Supportive care
Effect of Hybrid Breastfeeding Education on Breastfeeding Effectiveness and Postpartum Comfort
This randomized controlled study aims to determine the effect of hybrid-model breastfeeding education on breastfeeding effectiveness and postpartum comfort levels among primiparous women following vaginal birth.
The study will be conducted in the postpartum ward of Bilecik Training and Research Hospital between November 15, 2025, and November 15, 2026. The planned sample size is 66 women, with 33 participants assigned to the intervention group and 33 to the control group. Eligible participants will be randomly allocated to the study groups using the Randomizer website.
The inclusion criteria are being primiparous, having had a vaginal birth, having no obstetric, gynecological, or medical disease, having a healthy newborn, being willing to participate in the study, being able to read and write Turkish, and having an average postpartum comfort score of 3 or lower.
The intervention group will receive breastfeeding education using a hybrid model. The educational intervention will consist of a breastfeeding education brochure prepared by the researcher and reinforced through remote follow-up. The educational content will address breastfeeding practices and techniques. Education will be repeated until adequate feedback is obtained from the participant to demonstrate understanding of the information. Additional breastfeeding education will be provided by telephone on postpartum days 5, 15, and 30.
Participants in the control group will receive routine care provided in the study setting without the additional breastfeeding education intervention. Both groups will be assessed at baseline, 24-48 hours after birth, and on postpartum days 5, 15, and 30.
Data will be collected using a Personal Information Form, the Bristol Breastfeeding Assessment Tool, and the Postpartum Comfort Questionnaire. The Personal Information Form will collect sociodemographic, obstetric, and other relevant participant characteristics. Breastfeeding effectiveness will be assessed using the Bristol Breastfeeding Assessment Tool, which evaluates positioning, sucking, attachment, and swallowing. Postpartum comfort will be assessed using the Postpartum Comfort Questionnaire.
The primary purpose of the study is to evaluate whether hybrid-model breastfeeding education improves breastfeeding effectiveness and postpartum comfort compared with routine care. Outcomes will be assessed by comparing measurements between the intervention and control groups and examining changes over time.
The findings are expected to contribute to evidence regarding the effectiveness of hybrid-model breastfeeding education in supporting breastfeeding practices and improving postpartum comfort during the first month after childbirth.
1,081 studies on the registry are indexed under Breast Feeding; 217 are open to participants now.
This study's planned enrollment of 66 is below the median of 100 across 844 interventional studies indexed under Breast Feeding.
Browse Breast Feeding studies →Kutahya Health Sciences University is the lead sponsor of 219 studies on the registry; 50 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Behavioral: Hybrid-Model Breastfeeding Education
The intervention consists of hybrid-model breastfeeding education provided to women in the intervention group. The education will be delivered using a breastfeeding education brochure prepared by the researcher and reinforced through telephone-based follow-up. The educational content will address breastfeeding practices and techniques. Education will be repeated until adequate feedback is obtained from participants to confirm their understanding. Additional breastfeeding education will be provided by telephone on postpartum days 5, 15, and 30. Breastfeeding effectiveness and postpartum comfort will be assessed at baseline, 24-48 hours after birth, and on postpartum days 5, 15, and 30 using the Bristol Breastfeeding Assessment Tool and the Postpartum Comfort Questionnaire.
Breastfeeding Effectiveness
Breastfeeding effectiveness will be assessed using the Bristol Breastfeeding Assessment Tool, which evaluates positioning, sucking, attachment, and swallowing.
Time frame: Baseline, 24-48 hours after birth, and postpartum days 5, 15, and 30.
Plan to share: Undecided
No publications or documents are linked to this record.
Started Nov 2025 (actual). Primary completion is estimated for Nov 2026, 12 months after the start.
Of 502 non-industry interventional studies with no phase under Breast Feeding, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 12 months is close to that.
Counting every sponsor, half of 510 studies reached it within 12 months; a quarter within 6 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kutahya Health Sciences University →